Sunday, December 8, 2019

FORBES RICHEST - 100 INDIANS LIST - 2019



FORBES RICHEST

100 INDIANS LIST 2019




Forbes has released the 2019 India Rich list which is compiled using data from shareholding and financial information obtained from families and individuals, stock exchanges, analysts and Indian regulatory agencies.

The total wealth of the tycoons on the 2019 Rich List decreased by 8% to $452 billion from a year ago.  

Mukesh Ambani is the RICHEST INDIAN and there is huge gap between him and the Rest.

Ratan TATA is not in the List as his properties are in the name of Trusts.

Azim Premji of Wipro is now at 17 as he has been donating his incomes frequently.

Mukesh Ambani's JIO is moving ahead in Telecom. As the latest entrant in Telecom, it has no Old baggage and is beneficiary of all moves in Telecom Industry. Others were languishing but are now likely to become profitable after Tariff revision.

Infosys founders are mostly in this list. I don’t know if anybody has missed out.





 
Rank Name Net Worth (In $ Billion) Company
Age
1 Mukesh Ambani 51.4 Reliance Industries
62
2 Gautam Adani  15.7 Adani Ports & SEZ
57
3 Hinduja brothers 15.6 Ashok Leyland
83, 78, 73, 68
4 Pallonji Mistry 15 Shapoorji Pallonji Group
90
5 Uday Kotak  14.8 Kotak Mahindra Bank
60
6 Shiv Nadar 14.4 HCL Technologies
74
7 Radhakishan Damani 14.3 Avenue Supermarts
64
8 Godrej family 12 Godrej Group
NA
9 Lakshmi Mittal 10.5 ArcelorMittal
69
10 Kumar Mangalam Birla 9.6 Aditya Birla Group
52
11 Bajaj family 9.2 Bajaj Auto
NA
12 Cyrus Poonawalla 9.1 Serum Institute of India
78
13 Burman family 8.3 Dabur
NA
14 Sunil Mittal 7.6 Bharti Airtel
62
15 Dilip Shanghvi 7.55 Sun Pharmaceutical Industries
63
16 Madhukar Parekh 7.5 Pidilite Industries
73
17 Azim Premji 7.2 Wipro
74
18 Nusli Wadia 7.1 Britannia Industries
75
19 Benu Gopal Bangur 6.3 Shree Cement
88
20 Savitri Jindal 5.8 O.P. Jindal Group
69
21 Kuldip & Gurbachan Singh Dhingra  5.5 Berger Paints India

22 Kapil & Rahul Bhatia  5.4 Interglobe Aviation
87, 59
23 Ashwin Dani 4.8 Asian Paints
76
24 Harsh Mariwala 4.6 Marico
68
25 Kushal Pal Singh 4.35 DLF
88
26 M.A. Yusuff Ali 4.3 LuLu Group
63
27 Sudhir & Samir Mehta 4.15 Torrent Group
65, 56
28 Hasmukh Chudgar 4.1 Intas Pharmaceuticals
86
29 Vinod & Anil Rai Gupta 4 Havells India
74, 50
30 Karsanbhai Patel 3.9 Nirma
75
31 Mahendra Choksi 3.85 Asian Paints
78
32 Vikram Lal 3.8 Eicher Motors
77
33 Micky Jagtiani 3.7 Landmark Group
68
34 Pawan Munjal 3.65 Hero MotoCorp
65
35 Abhay Vakil 3.5 Asian Paints
68
36 Rajendra Agarwal 3.45 Macleods Pharmaceuticals
60
37 Murali Divi 3.4 Divi's Laboratories
68
38 Anil Agarwal 3.35 Vedanta Resources
66
39 P.P. Reddy 3.3 Megha Engineering & Infrastructure
62
40 Chandru Raheja 3.2 K. Raheja Corp
79
41 Singh family 3.18 Alkem Laboratories
NA
42 B.R. Shetty 3.15 NMC Health
77
43 Ravi Pillai 3.1 RP Group
66
44 M.G. George Muthoot 3.05 Muthoot Finance
69
45 Ajay Piramal 2.95 Piramal Enterprises
64
46 Pankaj Patel 2.8 Cadila Healthcare
66
47 Mangal Prabhat Lodha 2.65 Lodha Group
63
48 Rakesh Jhunjhunwala 2.6 Rare Enterprises
59
49 Kalanithi Maran 2.5 Sun TV Network
54
50 Jitendra Virwani 2.48 Embassy Property Development
53
51 N.R. Narayana Murthy 2.47 Infosys
73
52 Vivek Chaand Sehgal 2.45 Motherson Sumi Sytems
63
53 Ravi Jaipuria 2.4 RJ Corp
64
54 Kiran Mazumdar-Shaw 2.38 Biocon
66
55 Senapathy Gopalakrishnan 2.36 Infosys
64
56 Vijay Shekhar Sharma 2.35 Paytm
41
57 Shashi & Ravi Ruia 2.33 Essar Group
75, 70
58 Ramesh Juneja 2.3 Mankind Pharma
66
59 P.V. Ramprasad Reddy 2.25 Aurobindo Pharma
61
60 Rajan Raheja 2.22 Exide Industries
65
61 Gupta family 2.2 Lupin
NA
62 Abhay Firodia 2.12 Force Motors
74
63 Vikas Oberoi 2.11 Oberoi Realty
49
64 Amalgamations Group family 2.1 Tractors & Farm Equipment
NA
65 Murugappa family 2.09 Murugappa Group
NA
66 Baba Kalyani 2.07 Bharat Forge
70
67 Sunny Varkey 2.05 GEMS Education
62
68 Shyam & Hari Bhartia 2 Jubilant Group
66, 62
69 Vijay Chauhan 1.95 Parle Products
83
70 Salil Singhal 1.93 PI Industries
72
71 Leena Tewari 1.92 USV India
62
72 Byju Raveendran 1.91 Byju's
38
73 Sunder Genomal 1.9 Page Industries
65
74 Yusuf Hamied 1.89 Cipla
83
75 Mofatraj Munot 1.85 Kalpataru
74
76 Sridhar Vembu 1.83 Zoho
51
77 Harsh Goenka 1.82 RPG Group
61
78 Nandan Nilekani 1.81 Infosys
64
79 Sanjiv Goenka 1.8 RP-Sanjiv Goenka Group
58
80 Kishore Biyani 1.78 Future Group
58
81 Mahendra Prasad 1.77 Aristo Pharmaceuticals
79
82 Reddy family 1.76 Dr. Reddy's Laboratories
NA
83 Jain family 1.75 Bennett Coleman & Co.
NA
84 Anurang Jain 1.74 Endurance Technologies
57
85 Devendra Jain 1.73 Gujarat Fluorochemicals
90
86 Manohar Lal & Madhusudan Agarwal  1.7 Haldiram Snacks

87 Rajju Shroff 1.69 UPL
85
88 Anand Mahindra 1.65 Mahindra & Mahindra
64
89 K. Dinesh 1.61 Infosys
65
90 Sunil Vaswani 1.6 Stallion Group
56
91 Lachhman Das Mittal 1.59 Sonalika Group
88
92 Ranjan Pai 1.58 Manipal Group
46
93 Rajesh Mehta 1.57 Rajesh Exports
55
94 Bhavin & Divyank Turakhia 1.54 Media.net
39, 37
95 Rajesh Mehra 1.5 Jaquar Group
61
96 Bhadresh Shah 1.49 AIA Engineering
67
97 Acharya Balkrishna 1.47 Patanjali Ayurved
47
98 Sandeep Engineer 1.45 Astral Poly Technik
58
99 Shamsheer Vayalil 1.41 VPS Healthcare
42
100 S.D. Shibulal 1.4 Infosys
64

Sunday, November 17, 2019

IOL Chemicals and Pharmaceuticals Ltd - Q2 FY 20 RESULTS - REVIEW



IOL Chemicals and Pharmaceuticals Ltd
Q2 FY 20 RESULTS - REVIEW

About IOL Chemicals and Pharmaceuticals Limited (IOLCP)
Company was established in 1986 is one of the leading Active Pharmaceutical ingredients/ bulk drugs manufacturing Company and is a significant player in the specialty chemicals space with world class facilities. 

IOLCP  has wide presence across  major therapeutic categories  like,  Pain Management, anti-convulsants, anti-diabetes, anti- cholesterol and anti-platelets. 

IOLCP's  product  portfolio  includes  Active Pharmaceutical lngredients;   Ibuprofen,   Metformin,   Fenofibrate, Clopidogrel,  Lamotrigine,  Pantoprazole  and  specialty  chemicals  such  as  Ethyl Acetate,  lso Butyl Benzene, Mono Chiaro Acetic Acid and Acetyl Chloride. 

Company is World's largest producer of the Ibuprofen with an installed capacity of 12,000 TPA and  having backward  integrated manufacturing facility.  

The Company has DSIR approved R&D which is fully equipped to validate existing processes. 

The Central  and  State  Government approved  Effluent Treatment Plant (ETP)  had been  set up  with  zero  effluent discharge  system  along with  17  MW  captive  Co- Generation plant for self reliance. 

IOLCP's overseas customers are spread out across several  countries including UK, Austria, Belgium,  Hungry,  Spain, Germany,  Italy, Netherlands,  Switzerland, Portugal, Poland,  Ireland,  USA,  Australia,  Chile,  Peru,  Brazil,  Argentina,  Colombia,  Mexico, Indonesia,  South  Korea,  Thailand  etc.  

Products  are  sold  primarily  to  Branded Generic formulators both in India & Overseas
IOL has posted remarkable operational and financial performance for the second quarter of financial year 2019-20. It was after a consistent first quarter performance.

Quarter ended September 2019 vis a vis Quarter ended September 2018 

• Income from operations increased by 5 % to~Rs.452 crore from Rs.429 crore.
• EBIDTA increased by 68 % to~Rs.136 crore from Rs.81 crore.
• Net Profit increased by 132 % to~Rs.88 crore from Rs.38 crore.
• EPS increased by 125 % to Rs.15.42 from Rs.6.84.

Half year ended September 2019 vis a vis Half year ended September 2018 

• Income from operations increased by 19 % to~ 948 crore from Rs.794 crore.
• EBIDTA increased by 129 % to Rs.284 crore from Rs.124 crore.
• Net Profit increased by 226 % to Rs.173 crore from Rs.53 crore.
• EPS increased by 224 % to Rs.30.42 from Rs.9.40. 

Mr Vijay Garg, Joint Managing Director said :

"We are very delighted to announce consistently strong operational and financial performance during the 2ndquarter of the Financial Year 2019-20. 

We have successfully set up Unit VI to manufacture Pantoprazole with a capacity of 240 MT per annum which will enable to increase the revenue of the Company. 

He further added, we have made the pre-payment of term loan of aggregate amount of Rs.161.44 crore till date to reduce the financial cost of the Company."